New contraindication for co-cyprindiol

Cyproterone-containing medicines are now contraindicated in patients with a history of or existing meningioma, the MHRA has advised.

by Sandhiya Sodha
Co-cyprindiol is licensed to treat moderate to severe acne and hirsutism in female patients. | GETTY IMAGES
Co-cyprindiol is licensed to treat moderate to severe acne and hirsutism in female patients. | GETTY IMAGES

Sign in to continue

Sign In

Trouble signing in?

Reset password: Click here

Need help? Email us

Register

FREE

  • Limited free articles a month 
  • Free email bulletins

Register Now

Subscribe now

Benefits include:

  • Full site access
  • Subscriber exclusive content
  • Exclusive bulletins

Choose a package